Literature DB >> 2511811

[The syndrome of ovarian hyperstimulation].

M Germond1, M C Gaillard, A Senn.   

Abstract

The ovarian hyperstimulation syndrome (SHO) can be defined as an iatrogenic pathology induced by active substances administered for controlling follicular maturation and ovulation. The etiology, the physiopathology, the diagnostic and therapeutic methods available are discussed. A theoretical model, based on clinical data, allows identification of a set of criteria which should help determining prospectively the chances of development of such a pathology.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2511811     DOI: 10.1007/bf00935853

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  11 in total

1.  Delayed appearance and rupture of lutein cysts with hydatidiform mole. Report of a case.

Authors:  J KLEIN
Journal:  Obstet Gynecol       Date:  1963-01       Impact factor: 7.661

Review 2.  Ovarian hyperstimulation syndrome: a current survey.

Authors:  J G Schenker; D Weinstein
Journal:  Fertil Steril       Date:  1978-09       Impact factor: 7.329

3.  Effects of angiotensin II and some analogues on vascular permeability in the rabbit.

Authors:  A L Robertson; P A Khairallah
Journal:  Circ Res       Date:  1972-12       Impact factor: 17.367

Review 4.  The ovarian hyperstimulation syndrome.

Authors:  G Bettendorf; C Lindner
Journal:  Horm Metab Res       Date:  1987-11       Impact factor: 2.936

5.  Severe ovarian hyperstimulation after follicular aspiration.

Authors:  J P van der Merwe; W L Michell; T F Kruger
Journal:  S Afr Med J       Date:  1988-04-02

6.  Ascites in a case of twin pregnancy.

Authors:  J G Shenker; W Z Polishuk
Journal:  J Obstet Gynaecol Br Commonw       Date:  1967-06

7.  Clinical, endocrinologic, and intraovarian prostaglandin F responses to H-1 receptor blockade in the ovarian hyperstimulation syndrome: studies in the rabbit model.

Authors:  S M Pride; B Ho Yuen; Y S Moon
Journal:  Am J Obstet Gynecol       Date:  1984-03-01       Impact factor: 8.661

Review 8.  Induction of ovulation with clomiphene citrate (clomid).

Authors:  R W Kistner
Journal:  Obstet Gynecol Surv       Date:  1965-12       Impact factor: 2.347

9.  The use of human gonadotropins for the induction of ovulation in women with polycystic ovarian disease.

Authors:  C F Wang; C Gemzell
Journal:  Fertil Steril       Date:  1980-05       Impact factor: 7.329

10.  Management of ovarian hyperstimulation syndrome with chlorpheniramine maleate, mannitol, and invasive hemodynamic monitoring.

Authors:  B Kirshon; M C Doody; D B Cotton; W Gibbons
Journal:  Obstet Gynecol       Date:  1988-03       Impact factor: 7.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.